Search Results

PD 169316 50mg 50mg  | Purity Not Available

Adooq Bioscience

PD 169316 (PD169316) is a selective inhibitor of p38 MAPK.1 that inhibits p38 MAPK with an IC50 of 89 nM.

More Information Supplier Page

PD 169316 5mg 5mg  | Purity Not Available

Adooq Bioscience

PD 169316 (PD169316) is a selective inhibitor of p38 MAPK.1 that inhibits p38 MAPK with an IC50 of 89 nM.

More Information Supplier Page

PD 169316 25mg 25mg  | Purity Not Available

Adooq Bioscience

PD 169316 (PD169316) is a selective inhibitor of p38 MAPK.1 that inhibits p38 MAPK with an IC50 of 89 nM.

More Information Supplier Page

PD 169316 10mg 10mg  | Purity Not Available

Adooq Bioscience

PD 169316 (PD169316) is a selective inhibitor of p38 MAPK.1 that inhibits p38 MAPK with an IC50 of 89 nM.

More Information Supplier Page

JTT-705 50mg 50mg  | Purity Not Available

Adooq Bioscience

JTT-705 (Dalcetrapib) is a CETP inhibitor.Inhibition of CETP is a target to increase HDL-cholesterol and potentially reduce atherosclerosis.

More Information Supplier Page

JTT-705 5mg 5mg  | Purity Not Available

Adooq Bioscience

JTT-705 (Dalcetrapib) is a CETP inhibitor.Inhibition of CETP is a target to increase HDL-cholesterol and potentially reduce atherosclerosis.

More Information Supplier Page

JTT-705 25mg 25mg  | Purity Not Available

Adooq Bioscience

JTT-705 (Dalcetrapib) is a CETP inhibitor.Inhibition of CETP is a target to increase HDL-cholesterol and potentially reduce atherosclerosis.

More Information Supplier Page

JTT-705 10mg 10mg  | Purity Not Available

Adooq Bioscience

JTT-705 (Dalcetrapib) is a CETP inhibitor.Inhibition of CETP is a target to increase HDL-cholesterol and potentially reduce atherosclerosis.

More Information Supplier Page